1. Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related Parameters
    Rongfen Gao et al, 2015, BioMed Research International CrossRef
  2. Lack of Association between Genetic Polymorphisms of JAK-STAT Signaling Pathway Genes and Acute Anterior Uveitis in Han Chinese
    Ling Cheng et al, 2016, BioMed Research International CrossRef
  3. Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients
    Yichao Wang et al, 2017 CrossRef
  4. Evaluation of the efficacy and safety of β- d -mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial
    Mohammad Javad Fattahi et al, 2018, International Immunopharmacology CrossRef
  5. The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis
    Sonja Dulic et al, 2017, Pathobiology CrossRef
  6. Immune cells involved in the pathogenesis of ankylosing spondylitis.
    Alireza Rezaiemanesh et al, 2018, Biomed Pharmacother CrossRef
  7. Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis
    Jinlin Miao et al, 2018, Curr Rheumatol Rep CrossRef
  8. IL-17 in the immunopathogenesis of spondyloarthritis
    Leonie S. Taams et al, 2018, Nat Rev Rheumatol CrossRef
  9. Anti cytokine therapy in chronic inflammatory arthritis
    Charlotte Thompson et al, 2016, Cytokine CrossRef
  10. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
    Yu-feng Liu et al, 2018, Arthritis Res Ther CrossRef
  11. The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review
    Alessander Leyendecker Jr. et al, 2018, Front. Immunol. CrossRef
  12. Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach
    Kamal Abdolmohammadi et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  13. Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties
    Seyed Shahabeddin Mortazavi-Jahromi et al, 2018, Immunol Res CrossRef
  14. Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function
    Mehrzad Hajialilo et al, 2019, J Cell Biochem CrossRef
  15. Treg cells in autoimmunity: from identification to Treg-based therapies
    Lisa Göschl et al, 2019, Semin Immunopathol CrossRef
  16. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double‐blind, placebo‐controlled clinical trial
    Majid Ahmadi et al, 2019, J Cell Biochem CrossRef
  17. Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis.
    Huifang Guo et al, 0 CrossRef
  18. Acquired pure red cell aplasia in a patient with ankylosing spondylitis- a case report and literature review
    Xianfang Shao et al, 2019, Medicine CrossRef
  19. Ankylosing spondylitis: etiology, pathogenesis, and treatments.
    Wei Zhu et al, 2019, Bone Res CrossRef
  20. Association Between Intercellular Adhesion Molecule-1, -2, -3 Plasma Levels and Disease Activity of Ankylosing Spondylitis in the Chinese Han Population
    Ruyin Liu et al, 2016, SPINE CrossRef
  21. Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis
    Jianing Wang et al, 2016, Cytokine CrossRef
  22. Assay of Peripheral Regulatory Vδ1 T Cells in Ankylosing Spondylitis and its Significance
    Hongliang Wang et al, 2016, Med Sci Monit CrossRef
  23. The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis
    Na-Lin Lai et al, 2019, Journal of Immunology Research CrossRef
  24. Treg-promoted New Bone Formation Through Suppressing TH17 by Secreting Interleukin-10 in Ankylosing Spondylitis
    Fan Xu et al, 2019, SPINE CrossRef
  25. Oxidative stress and immunological biomarkers in Ankylosing spondylitis patients
    Shahla Danaii et al, 2019, Gene Reports CrossRef
  26. Serum Deoxyribonuclease 1-like 3 is a potential biomarker for diagnosis of ankylosing spondylitis
    Yifan Sun et al, 2019, Clinica Chimica Acta CrossRef
  27. Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness
    Patricia Ruiz-Limon et al, 2020, J Biomed Sci CrossRef
  28. TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis
    Mingcan Yang et al, 2020, Arthritis Res Ther CrossRef
  29. High frequency of circulating follicular helper T cells is correlated with B cell subtypes in patients with ankylosing spondylitis
    Siqi Long et al, 2018, Exp Ther Med CrossRef
  30. Usefulness of complex bacteriological and serological analysis in patients with spondyloarthritis
    Daniela Cristea et al, 2019, Exp Ther Med CrossRef
  31. Modulation of T-Cell Activation Markers Expression by the Adipose Tissue–Derived Mesenchymal Stem Cells of Patients with Rheumatic Diseases
    Ewa Kuca-Warnawin et al, 2020, Cell Transplant CrossRef
  32. The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
    Hiroyuki Tsukazaki et al, 2020, IJMS CrossRef
  33. Semaphorin 4D Induces an Imbalance of Th17/Treg Cells by Activating the Aryl Hydrocarbon Receptor in Ankylosing Spondylitis
    Jianmin Xie et al, 2020, Front. Immunol. CrossRef
  34. Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation
    Ewa Kuca-Warnawin et al, 2021, Cells CrossRef
  35. null
    Yang Du et al, 2021 CrossRef
  36. Phenotypic characterization of circulating endothelial cells induced by inflammation and oxidative stress in ankylosing spondylitis
    Ayindrila Saha et al, 2021, Free Radical Research CrossRef
  37. Osteoimmunological insights into the pathogenesis of ankylosing spondylitis
    Lifei Liu et al, 2021, J Cell Physiol CrossRef
  38. Novel immune cell phenotypes in spondyloarthritis pathogenesis
    Daniele Mauro et al, 2021, Semin Immunopathol CrossRef
  39. Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
    Claudia Schinocca et al, 2021, Front. Immunol. CrossRef
  40. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights
    Zoya Qaiyum et al, 2021, Semin Immunopathol CrossRef
  41. Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis
    Akihiro Nakamura et al, 2021, Curr Rheumatol Rep CrossRef
  42. Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
    Fabiola Atzeni et al, 2021, ITT CrossRef
  43. Potential Role and Impact of Peripheral Blood Mononuclear Cells in Radiographic Axial Spondyloarthritis-Associated Endothelial Dysfunction
    Patricia Ruiz-Limon et al, 2021, Diagnostics CrossRef
  44. null
    Maryam Akhtari, 2022 CrossRef
  45. Cellular and molecular diversity in spondyloarthritis
    G.R. Gulino et al, 2021, Seminars in Immunology CrossRef
  46. The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases
    S.P. Déo-Gracias Berry et al, 2021, International Immunopharmacology CrossRef
  47. Elevated Th17 cells are associated with cardiovascular complications in ankylosing spondylitis
    Tingting Ding et al, 2021 CrossRef
  48. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19+ B cells in patients with ankylosing spondylitis
    Yu Zhang et al, 2022, Clin Rheumatol CrossRef
  49. FOXO3a Alleviates the Inflammation and Oxidative Stress via Regulating TGF-β and HO-1 in Ankylosing Spondylitis
    Shanshan Xu et al, 2022, Front. Immunol. CrossRef
  50. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
    Liuting Zeng et al, 2022, Front. Immunol. CrossRef
  51. Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials
    Liuting Zeng et al, 2022, Front. Immunol. CrossRef
  52. Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation
    Jeonghyeon Moon et al, 2022, Front. Immunol. CrossRef
  53. How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management
    Mauro Fatica et al, 2022, Curr Rheumatol Rep CrossRef
  54. Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis
    Marino Paroli et al, 2023, IJMS CrossRef
  55. A Predictive Disease Risk Model for Ankylosing Spondylitis: Based on Integrated Bioinformatic Analysis and Identification of Potential Biomarkers Most Related to Immunity
    Wenxin Gao et al, 2023, Mediators of Inflammation CrossRef
  56. Screening and identification of key chromatin regulator biomarkers for ankylosing spondylitis and drug prediction: evidence from bioinformatics analysis
    Han Wang et al, 2023, BMC Musculoskelet Disord CrossRef
  57. Platelet-Derived Microparticles and Autoimmune Diseases
    Xiaoshuai Li et al, 2023, IJMS CrossRef